Transüretral prostat cerrahisinde kullanılan farklı enerji kaynaklarının doku penetrasyon derinliklerinin karşılaştırılması

Year 2013, Volume: 8 Issue: 1, 34 - 39, 01.01.2013

Hakan Polat Volkan Tuğcu Doğukan Sökmen Ali İhsan Taşçı

Abstract

Amaç: BPH tedavisinde kullanılan monopolar TURP, bipolar TURP ve 120 W Lithium triborate LBO laser uygulamalarının çevre dokularda oluşturduğu penetrasyon derinliklerini insan prostat dokusu üzerinde belirlemek ve birbirleri ile karşılaştırmak. Gereç ve Yöntemler: Transüretral prostatektomi planlanan 39 hasta non-randomize olarak üç gruba ayrıldı. İlk iki grupta monopolar grup-1 ve bipolar grup-2 elektrokoter kullanılarak prostat rezeksiyonu, 1 saniye ve 2 saniye koagülasyonlar yapıldı. Alınan doku materyalleri histopatolojik olarak değerlendirildi. Grup3’te LBO laser ile prostat vaporizasyon ve koagülasyonları uygulandıktan sonra TUR ile doku örneklemesi yapılarak alınan örnekler histopatolojik olarak değerlendirildi. Oluşan koagülasyon zonları belirlenerek karşılaştırıldı Bulgular: Gruplara göre ortalama koagülasyon derinliği grup 1’de 221,33±9,33, grup 2’de 248,33±17,18, grup 3’de 2103,33±101 μm olarak belirlenmiştir. Her bir grubun koagulasyon zonu karşılaştırıldı ve 120 W Lityum triborat LBO lazer grubun koagülasyon zonu derinliği monopolar ve bipolar TURP grubundan daha derin bulundu p 0.05 . Sonuç: 120 W Lityum triborat lazer LBO tarafından çevre dokularda oluşturulan termal hasar monopolar ve bipolar TURP’ye göre daha derin katmanlara ulaşmaktadır. Bu etki, daha iyi kanama kontrolü, daha iyi bir görüntü ve daha az kan kaybına neden olabilir

Keywords

bipolar koter , BPH , Lithium triborate laser , monopolar koter , transüretral prostat cerrahisi

Comparison of tissue penetration depths of different energy sources used in transurethral prostatic surgery

Abstract

Objective: To evaluate and compare tissue penetration depths of monopolar TURP, bipolar TURP and 120 W Lithium triborate LBO laser in human prostatic tissue. Materials and Methods: 39 patients scheduled for transurethral prostatectomy were divided to 3 groups, nonrandomly. In monopolar group group-1 and bipolar group group-2 prostate was resected by electrocautery and coagulation was applied for 1sec and 2sec. Resected tissue samples were examined histopathologically. In group-3, following prostate vaporisation and coagulation by 120 W Lithium triborate LBO laser, TUR were performed for tissue sampling and histopathologic examination. Composed coagulation zones were detected and compared. Results: Resection groups, mean values than the other groups, 1 second and 2 seconds after the process of coagulation coagulation zones were compared in all groups formed by the LBO laser coagulation, monopolar and bipolar TURP zone depths were found to be statistically significantly higher. The difference between monopolar and bipolar TURP groups was not statitistically significant p>0.05 . Conclusion: Termal injury in the surrounding tissue generated by 120 W Lithium triborate LBO laser reached to deeper layers compared with termal injury of monopolar and bipolar TURP. This effect may obtain better homeostasis, visualization and lesser blood loss nevertheless periprostatic structures may be negatively affected. These effects should be evaluated with better histologic identifications and there is need for advanced studies evaluating erectile functions objectively.

Keywords

bipolar cautery , BPH , 120 W Lithium triborate LBO laser , monopolar cautery , transurethral prostatic surgery

References

• AUA Practice Guidelines Committe. AUA guidelines on management of benign prostatic hyperplasia (2003). Chap- ter I: Diagnosis and treatment recommendations. J Urol 2003; 170: 530-47.
• de la Rosette JJ. What we do and don’t know about benign prostatic hyperplasia. Curr Opin Urol 2000; 10: 1-2.
• Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9.
• Kanik EA, Erdem E, Abidinoglu D, Acar D, Akbay E, Ulusoy E. Can the outcome of transurethral resection of the pros- tate be predicted preoperatively? Urology 2004; 64: 302-5.
• Haupt G, Pannek J, Benkert S, Heinrich C, Schulze H, Sen- ge T. Transurethral resection of the prostate with microp- rocessor controlled electrosurgical unit. J Urol 1997; 158: 497-501.
• Barba M, Fastenmeier K, Hartung R: Electrocautery: Prin- ciples and practice. J Endourol 2003; 17: 541-55.
• Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999; 83: 227-37.
• Fried NM. New laser treatment approaches for benign pros- tatic hyperplasia. Curr Urol Rep 2007; 8:47-52.
• Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia. Eur Urol 2006; 49: 961-9.
• Botto H, Lebret T, Barre P, Orsoni JL, Herve JM, Lugagne PM. Electrovaporization of the prostate with the Gyrus de- vice. J Endourol 2001; 15: 313- 6.
• Jaidane M, Arfa NB, Hmida W, Hidoussi A, Slama A, Sorba NB, Mosbah F. Effect of transurethral resection of the pros- tate on erectile function: a prospective comparative study. Int J Impot Res. 2010; 22: 146-51.
• Lindner A, Golomb J, Korczak D, Keller T, Siegel Y. Effects of prostatectomy on sexuel function. Urology 1991; 38: 26- 8.
• Tscholl R, Largo M, Poppinghaus H, Recker F, Subotic B. Incidence of erectile impotance secondary to transurethral resection of benign prostatic hyperplasia assessed by preo- perative and postoperative Snap Gauge tests. J Urol 1995; 153: 1491-3.
• Soderdahl D, Knight R, Hansberry K. Erectile dysfuncti- on following transurethral resection of the prostate. J Urol 1996; 156: 1354-6.
• Bieri S, Iselin CE, Rohner S. Capsuler perforation locali- zation and adenoma size as prognosis indicator of erecti- le dysfunctional after transurethral prostatectomy. Scand J Urol Nephrol 1997; 31: 545-8.
• Ibrahim AI, El-Malik EM, Ismail G, Rashid M, Al Zahra- ni AB. Risk factors associated with sexual dysfunction af- ter transurethral resection of the prostate. Ann Saudi Med 2002; 22: 8–12.
• Poulakis V, Ferakis N, Witzsch U, de Vries R, Becht E. Erec- tile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500 patients. Asian J Androl 2006; 8: 69–74.
• Bolt JW, Evans C, Marshall VR. Sexual dysfunction after prostatectomy. Br J Urol 1987; 59: 319-22.
• Zohar J, Meiraz D, Maoz B, Durst N. Factors influencing se- xual activity after prostatectomy: a prospective study. J Urol 1976; 116: 332.
• Lefaucheur JP, Yiou R, Salomon L, Chopin DK, Abbou CC. Assessment of penile small nerve fiber damage after transu- rethral resection of the prostate by measurement of penile thermal sensation. J Urol 2000; 164: 1416-9.
• Mueller NM, Mueller EJ. KTP photoselective laser vapori- zation of the prostate: indications, procedure and nursing implications. Urol Nurs 2004; 24:373-8.
• Susani M, S, Kratzik C, Vingers L, Marberger M. Morpho- logy of tissue destruction induced by focused ultrasound. Eur Urol 1993;23: 34-8.
• Wendt-Nordahl G, Häcker A, Reich O, Djavan B, Alken P, Michel MS. The Vista system: a new bipolar resection devi- ce for endourological procedures: comparison with conven- tional resectoscope. Eur Urol 2004; 46: 586-90.
• Wendt-Nordahl G, Häcker A, Fastenmeier K, Knoll T, Re- ich O, Alken P, Michel MS. New bipolar resection device for transurethral resection of the prostate: first ex-vivo and in-vivo evaluation. J Endourol 2005; 19: 1203-9.
• Huang X, Wang XH, Qu LJ, Pu XY, Zeng X. Bipolar ver- sus monopolar transurethral resection of prostate: patholo- gic study in canines. Urology 2007; 70: 180-4.
• Seitz M, Ruszat R, Bayer T, Tilki D, Bahcmann A, Stief C, Sroka R, Reich O. Ex vivo and in vivo investigations of the novel 1470nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci 2009; 24: 419-24.
• Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Hacker A. 980-nm diode laser: A novel laser technology for vaporization of the prostate. Eur Urol 2007; 52: 1723-8.
• Heinrich E, Wendt-Nordahl G, Honeck P, Alken P, Knoll T, Michel MS, Häcker A. 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 2010; 24: 75-9.
• Kang HW, Jebens D, Malek RS, Mitchell G, Koullick E. La- ser vaporization of bovine prostate: a quantitative compa- rison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol 2008; 180: 2675-80.